Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2019-11-11 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
108年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes specific financial figures, investment methods, and regulatory approval limits. The content is structured as a regulatory disclosure rather than a full financial report or announcement. The document length is short (1291 characters), and it does not contain comprehensive financial statements or management discussion. It is a regulatory filing providing specific investment information as required by authorities, fitting best under the category of Regulatory Filings (RNS).
2019-11-11 Chinese
108年第3季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the third quarter of the fiscal year 108 (2019), with detailed financial data including cash flows from operating, investing, and financing activities. The presence of actual financial figures and the coverage of a specific interim period indicate this is a comprehensive financial report for a period shorter than a full fiscal year. The document length is 2487 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2019
2019-11-11 Chinese
108年第3季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial figures for the third quarter of the 108th year (Taiwan calendar, corresponding to 2019) and year-to-date figures. It includes revenue, costs, expenses, profit, and earnings per share data. The presence of actual financial data and detailed accounting items indicates this is a financial report rather than a brief announcement or certification. The document length is 3091 characters, which is relatively short but contains substantive financial data, consistent with an Interim / Quarterly Report. There is no indication that this is an annual report or a full 10-K equivalent, nor is it a simple announcement or certification. Therefore, the best classification is Interim / Quarterly Report (IR). 9M 2019
2019-11-11 Chinese
108年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific dates such as 108年09月30日 (which corresponds to 2019 Q3 in the ROC calendar). The content includes actual financial figures for assets, liabilities, and equity, indicating it is a substantive financial report. The length is 3931 characters, which is under 5000 characters, but the document itself contains detailed financial statements rather than just an announcement or a link to a report. The presence of quarterly financial data suggests this is an Interim / Quarterly Report rather than an Annual Report or Earnings Release. There is no indication that this is a certification or a simple announcement. Therefore, the document is best classified as an Interim / Quarterly Report (IR). 9M 2019
2019-11-11 Chinese
108年第3季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed tables of consolidated equity changes, including items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, treasury stock, and total equity attributable to the parent company and non-controlling interests. The data covers specific fiscal periods (e.g., the first three quarters of the 108th and 107th years in the Taiwanese calendar, corresponding to 2019 and 2018). The document is 4305 characters long, which is relatively short but contains substantive financial data rather than just an announcement or a link to a report. The content is consistent with a financial statement or report that provides detailed equity changes over an interim period rather than a full annual report. Therefore, this document fits the definition of an Interim / Quarterly Report (IR), as it provides comprehensive financial data for a period shorter than a full fiscal year (the first three quarters). 9M 2019
2019-11-11 Chinese
108年10月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, managers, and their family members. It shows changes in shareholdings, types of shares held, and related notes. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate filings. There is no indication of it being a full financial report, earnings release, or regulatory announcement. The document is a report of personal share transactions by company directors and executives, fitting the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data, not just an announcement or certification.
2019-11-06 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.